Immune Pathways & Development of Sarcoidosis
Trial Objectives
The purpose of this study is to learn more about patients who have sarcoidosis and those who do not in order to define different types of sarcoidosis and what may predict how the disease develops over time.
Who Can Participate
Adult nonsmokers who have biopsy-proven sarcoidosis and who are not on immunosuppressive therapy may be eligible to participate.
Adult nonsmokers who do not have an autoimmune disease and/or presence of any other serious disease and who are not on immunosuppressive therapy may be eligible to participate.
Age: 18+ Gender: Any
Estimated Time Commitment
Up to 2 visits
Time Commitment Details
One blood draw and one bronchoscopy, a procedure that allows doctors to examine your airways.
Payment & Reimbursement
Payment: Provided
Travel Reimbursement: Not Available
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
National Institutes of Health
Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit.
Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study.
Principal Investigators
Lisa A. Maier, MD, MSPH, FCCP
Request more Information
By completing this form, you agree to learn more about this study and see if you qualify.